Most of us have experienced it: a deadline approaches, the task is perfectly doable, yet instead of starting, we suddenly ...

Conspiracies might be fun to entertain. But the "big lie" tactic destroys your judgment and credibility. Find out why, and ...

Let's look at the pros and cons of going full AI to help you understand how the value and purpose of software development ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. If you close one eye or put a finger to your ear, there’s an ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

Here's why Metallica stopped using guitar amps live, according to James Hetfield's guitar tech. Metallica fans may or may not have even noticed that the rockers don't have a bunch of amps lined up ...

We hear it all the time in true crime podcasts, headlines and neighborhood chatter: Call the cops. The cops showed up. Good cop, bad cop. But have you ever stopped to investigate where the word cop ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

In recent years, ChatGPT has exploded in popularity, with nearly 200 million users pumping a total of over a billion prompts into the app every day. These prompts may seem to complete requests out of ...

On September 1st, the author and statistician Nate Silver wrote a post on X diagnosing a new condition: “Blueskyism,” so named for the decentralized social network that has emerged as a competitor to ...